Literature DB >> 7552497

Validity of the Karnofsky Performance Status in an HIV-infected sample.

M W O'Dell1, D P Lubeck, P O'Driscoll, S Matsuno.   

Abstract

The Karnofsky Performance Status (KPS) is the most widely used health status measure in human immunodeficiency virus (HIV) medicine and research. Because there are limited data on KPS metric properties in this setting, we present evidence of the construct validity of the KPS in a sample of HIV-infected persons using data from the AIDS Time-Oriented Health Outcome Study (ATHOS). The sample consisted of 160 primarily white, homosexual/bisexual men with a mean age of 45 years and a mean KPS score of 82 (range, 40-100). Ninety percent were classified in Centers for Disease Control (CDC) clinical category B or C. Pearson's product-moment correlations were strong between the KPS and measures of global health status, physical disability, numbers of symptoms, CDC clinical category, social function, days off work, and energy/fatigue (r = 0.39-0.52, p < 0.0001). Correlations with measures of mental health and cognition were less impressive but statistically significant. Analysis of variance followed by Student Newman-Keuls test showed significant differences among three KPS groupings for global health status but not for physical disability. Regression analysis indicated three significant variables accounting for KPS variance: visual analogue global health status (27%), days off work (10%), and energy/fatigue (1.7%). We conclude that the upper range of the KPS reflects global health status better than physical performance and much better than psychosocial constructs, in persons with HIV infection. Further research examining the ability of the KPS to detect clinically significant change over time is needed.

Entities:  

Mesh:

Year:  1995        PMID: 7552497

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  11 in total

1.  Putting Wilson and Cleary to the test: analysis of a HRQOL conceptual model using structural equation modeling.

Authors:  Karen H Sousa; Oi-Man Kwok
Journal:  Qual Life Res       Date:  2006-05       Impact factor: 4.147

2.  Tensor-based Multi-view Feature Selection with Applications to Brain Diseases.

Authors:  Bokai Cao; Lifang He; Xiangnan Kong; Philip S Yu; Zhifeng Hao; Ann B Ragin
Journal:  Proc IEEE Int Conf Data Min       Date:  2014-12

3.  Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults.

Authors:  Hyun J Lim; Alphonse Okwera; Harriet Mayanja-Kizza; Jerrold J Ellner; Roy D Mugerwa; Christopher C Whalen
Journal:  HIV Clin Trials       Date:  2006 Jul-Aug

4.  Physicians' assessments of the utility of health states associated with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection.

Authors:  D K Owens; A B Cardinalli; R F Nease
Journal:  Qual Life Res       Date:  1997-01       Impact factor: 4.147

5.  Assessment of quality of life in early stage HIV-infected persons: data from the AIDS Time-oriented Health Outcome Study (ATHOS).

Authors:  D P Lubeck; J F Fries
Journal:  Qual Life Res       Date:  1997-08       Impact factor: 4.147

6.  How do existing HIV-specific instruments measure up? Evaluating the ability of instruments to describe disability experienced by adults living with HIV.

Authors:  Kelly K O'Brien; Ahmed M Bayoumi; Carol Strike; Nancy L Young; Kenneth King; Aileen M Davis
Journal:  Health Qual Life Outcomes       Date:  2010-08-19       Impact factor: 3.186

7.  Poor Performance Status Is Associated With Increased Mortality in Patients With Cirrhosis.

Authors:  Eric S Orman; Marwan Ghabril; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-01       Impact factor: 11.382

8.  Personality and Everyday Functioning in Older Adults With and Without HIV.

Authors:  Rodica Ioana Damian; Surizaday Serrano; Anastasia Matchanova; Erin E Morgan; Steven Paul Woods
Journal:  J Clin Psychol Med Settings       Date:  2021-05-25

9.  Low levels of frailty in HIV-positive older adults on antiretroviral therapy in northern Tanzania.

Authors:  Clare Bristow; Grace George; Grace Hillsmith; Emma Rainey; Sarah Urasa; Sengua Koipapi; Aloyce Kisoli; Japhet Boni; Grace Anderson Saria; Sherika Ranasinghe; Marcella Joseph; William K Gray; Marieke Dekker; Richard W Walker; Catherine L Dotchin; Elizabeta Mukaetova-Ladinska; William Howlett; Philip Makupa; Stella-Maria Paddick
Journal:  J Neurovirol       Date:  2021-01-11       Impact factor: 2.643

10.  Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023].

Authors:  Dale Rublee; Steven M Opal; Wolfgang Schramm; Heinz-Otto Keinecke; Sigurd Knaub
Journal:  Crit Care       Date:  2002-06-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.